Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ehrenforth

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Thrombosis and Haemostasis|April 8, 1998
High prevalence of factor V R506Q mutation in German thrombophilic and normal populationS Ehrenforth, B Zwinge, I Scharrer
Deutsche Medizinische Wochenschrift (1946)|November 3, 1995
[Phenprocoumon-induced necrotizing hepatitis]S Ehrenforth, I Scharrer, G Herrmann
Seminars in Thrombosis and Hemostasis|May 18, 1999
Liver damage induced by coumarin anticoagulantsS Ehrenforth, J F Schenk, I Scharrer
Thrombosis and Haemostasis|August 1, 1995
Acquired activated protein C-resistance in patients with lupus anticoagulantsS Ehrenforth, K P Radtke, I Scharrer
Lancet (London, England)|October 9, 1993
Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentratesM Funk, U Ebener, W Kreuz, et al.
Cancer Detection and Prevention|January 1, 1997
Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancerC Ruppert, S Ehrenforth, I Scharrer, et al.
Lancet (London, England)|July 25, 1992
Factor VIII inhibitors in haemophiliacsS Ehrenforth, W Kreuz, I Scharrer, et al.
Transfusion|January 1, 1996
Hepatitis C and pasteurized C1-inhibitor concentrateD Klarmann, W Kreuz, J Joseph-Steiner, et al.
European Journal of Pediatrics|January 7, 1999
Severe factor V deficiency presenting as subdural haematoma in the newbornS Ehrenforth, D Klarmann, B Zabel, et al.
Thrombosis and Haemostasis|November 1, 1994
Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitorsS Ehrenforth, W Kreuz, M Funk, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Thrombosis and Haemostasis|April 8, 1998
High prevalence of factor V R506Q mutation in German thrombophilic and normal populationS Ehrenforth, B Zwinge, I Scharrer
Deutsche Medizinische Wochenschrift (1946)|November 3, 1995
[Phenprocoumon-induced necrotizing hepatitis]S Ehrenforth, I Scharrer, G Herrmann
Seminars in Thrombosis and Hemostasis|May 18, 1999
Liver damage induced by coumarin anticoagulantsS Ehrenforth, J F Schenk, I Scharrer
Thrombosis and Haemostasis|August 1, 1995
Acquired activated protein C-resistance in patients with lupus anticoagulantsS Ehrenforth, K P Radtke, I Scharrer
Lancet (London, England)|October 9, 1993
Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentratesM Funk, U Ebener, W Kreuz, et al.
Cancer Detection and Prevention|January 1, 1997
Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancerC Ruppert, S Ehrenforth, I Scharrer, et al.
Lancet (London, England)|July 25, 1992
Factor VIII inhibitors in haemophiliacsS Ehrenforth, W Kreuz, I Scharrer, et al.
Transfusion|January 1, 1996
Hepatitis C and pasteurized C1-inhibitor concentrateD Klarmann, W Kreuz, J Joseph-Steiner, et al.
European Journal of Pediatrics|January 7, 1999
Severe factor V deficiency presenting as subdural haematoma in the newbornS Ehrenforth, D Klarmann, B Zabel, et al.
Thrombosis and Haemostasis|November 1, 1994
Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitorsS Ehrenforth, W Kreuz, M Funk, et al.
Pageof 4